Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Adverum Biotechnologies (ADVM) Earnings Date, Estimates & Call Transcripts

Adverum Biotechnologies logo

Adverum Biotechnologies Earnings Summary

Adverum Biotechnologies released Q3 2025 earnings on November 12, 2025, reporting an EPS of -$2.03, which missed analysts' consensus estimates of -$1.80 by $0.23. With a trailing EPS of -$8.58, Adverum Biotechnologies' earnings are expected to decrease next year, from ($4.92) to ($5.20) per share.

Consensus EPS
(Nov. 12)
-$1.80
Actual EPS
(Nov. 12)
-$2.03 Missed By -$0.23
Get Adverum Biotechnologies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adverum Biotechnologies and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ADVM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Adverum Biotechnologies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$1.98-$1.98-$1.98
Q2 20261-$2.00-$2.00-$2.00
Q3 20261-$2.09-$2.09-$2.09
Q4 20261-$2.16-$2.16-$2.16

Adverum Biotechnologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2025Q3 2025-$1.80-$2.03 -$0.23-$2.03$12.66M-
8/12/2025Q2 2025-$2.24-$2.34 -$0.10-$2.34--
4/15/2025Q4 2024-$1.34-$1.96 -$0.62-$1.96--
11/4/2024--$1.20-$1.30 -$0.10-$1.30$0.50M$1.00M
8/12/2024Q2 2024-$1.47-$0.89+$0.58-$0.89$0.53M-

Data powered by Fiscal.ai.

Adverum Biotechnologies Earnings - Frequently Asked Questions

Adverum Biotechnologies (NASDAQ:ADVM) last announced its quarterly earning data on Wednesday, November 12, 2025. Learn more on ADVM's earnings history.

In the previous quarter, Adverum Biotechnologies (NASDAQ:ADVM) missed the analysts' consensus estimate of ($1.80) by $0.23 with a reported earnings per share (EPS) of ($2.03). Learn more on analysts' earnings estimate vs. ADVM's actual earnings.

Adverum Biotechnologies (NASDAQ:ADVM) has a recorded net income of -$130.93 million. ADVM has generated -$8.58 earnings per share over the last four quarters.

Adverum Biotechnologies' earnings are expected to decrease from ($4.92) per share to ($5.20) per share in the next year.


This page (NASDAQ:ADVM) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners